Leaflet RINONEF-T nasal drops, solution


Indicated for: ocular inflammation with congestion and bacterial component

Route of administration: nasal

Substance: naphazoline + neomycin + dexamethasone (ocular decongestant, aminoglycoside antibiotic and corticosteroid)

ATC: R01AB05 (Respiratory system | Decongestants and other nasal preparations for topical use | Sympathomimetics, combinations excl. corticosteroids)

Precautions:
Dizziness / vertigo
Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Anaphylaxis
Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Glaucoma warning
Glaucoma warning

Use caution if you have glaucoma or increased eye pressure.

Hyperglycemia
Hyperglycemia

This medicine may increase blood sugar.

Immunosuppression / infection risk
Immunosuppression / infection risk

This medicine may increase the risk of infections.

Nephrotoxicity
Nephrotoxicity

This medicine may affect the kidneys.

Ototoxicity
Ototoxicity

This medicine may affect hearing or balance.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Cardiac risk / QT prolongation / arrhythmias
Cardiac risk / QT prolongation / arrhythmias

This medicine may increase the risk of heart rhythm disturbances.

Vision disturbances
Vision disturbances

This medicine may cause vision disturbances.

General data about RINONEF-T

  • Substance: naphazoline + neomycin + dexamethasone
  • Date of last drug list: 01-07-2013
  • Commercial code: W02159001
  • Pharmaceutical form: nasal drops, solution
  • Packing volume: 10ml
  • Product type: generic
  • Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Marketing authorisation

  • Manufacturer: TIS FARMACEUTIC S.A. - ROMANIA
  • Holder: TIS FARMACEUTIC S.A. - ROMANIA
  • Number: 13361/2020/01
  • Shelf life: 2 years